TODAY'S HEADLINES
U.S. life expectancy for people with cancer hit another all-time high, rising over 50 million life-years after diagnosis, according to statistics collected through the Value of Medical Innovation initiative, led by the Center for Medicine in the Public Interest. » More |
|
The newly enrolled individuals in the healthcare exchanges will be faced with higher out-of-pocket costs for their medications than those who receive insurance through their employers, according to an analysis by Avalere Health of more than 600 health plans in the exchanges. » More |
|
FDA approved umeclidinium and vilanterol inhalation powder (AnoroEllipta,GlaxoSmithKline and Theravance) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. » More |
|
The American Pharmacists Association is asking pharmacists to share their best tips for the promotion of patient care services by pharmacists at the upcoming APhA 2014 Annual Meeting and Exposition. » More |
Continuing Education
This month, Drug Topics offers the second of a two-part CPE series, "MTM considerations in multiple sclerosis." Earn up to 2 credits by completing this knowledge-based activity. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career. |
|
|
Like
Tweet
